Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$191.89 - $259.92 $79.9 Million - $108 Million
416,625 New
416,625 $84.1 Billion
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $83.5 Million - $106 Million
423,554 New
423,554 $92.3 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $11.4 Million - $15.6 Million
-62,369 Reduced 11.44%
482,726 $95 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $3.95 Million - $5.85 Million
19,329 Added 3.68%
545,095 $117 Million
Q1 2022

May 11, 2022

BUY
$255.51 - $362.11 $158,671 - $224,870
621 Added 0.12%
525,766 $149 Million
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $19.3 Million - $24.6 Million
54,853 Added 11.66%
525,145 $198 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $16.9 Million - $20.8 Million
45,418 Added 10.69%
470,292 $194 Million
Q2 2021

Aug 11, 2021

SELL
$294.17 - $371.65 $26.1 Million - $33 Million
-88,777 Reduced 17.28%
424,874 $157 Million
Q1 2021

May 13, 2021

SELL
$249.67 - $299.48 $8.97 Million - $10.8 Million
-35,926 Reduced 6.54%
513,651 $149 Million
Q4 2020

Feb 09, 2021

SELL
$222.0 - $252.62 $539,682 - $614,119
-2,431 Reduced 0.44%
549,577 $137 Million
Q3 2020

Nov 12, 2020

SELL
$175.56 - $226.45 $3.62 Million - $4.67 Million
-20,610 Reduced 3.6%
552,008 $125 Million
Q2 2020

Aug 12, 2020

SELL
$118.84 - $189.72 $2.02 Million - $3.23 Million
-17,004 Reduced 2.88%
572,618 $99.8 Million
Q1 2020

May 06, 2020

SELL
$98.9 - $178.34 $22.3 Million - $40.3 Million
-225,915 Reduced 27.7%
589,622 $74.4 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $18.3 Million - $22.1 Million
-144,992 Reduced 15.1%
815,537 $125 Million
Q3 2019

Nov 07, 2019

SELL
$125.07 - $143.67 $2.21 Million - $2.54 Million
-17,654 Reduced 1.8%
960,529 $127 Million
Q2 2019

Aug 12, 2019

BUY
$123.4 - $148.55 $39.9 Million - $48.1 Million
323,625 Added 49.44%
978,183 $139 Million
Q1 2019

May 14, 2019

SELL
$104.82 - $146.73 $1.55 Million - $2.17 Million
-14,770 Reduced 2.21%
654,558 $95.1 Million
Q4 2018

Feb 11, 2019

SELL
$105.09 - $137.23 $9.01 Million - $11.8 Million
-85,753 Reduced 11.36%
669,328 $75.8 Million
Q3 2018

Nov 09, 2018

SELL
$112.11 - $134.54 $3.28 Million - $3.94 Million
-29,268 Reduced 3.73%
755,081 $0
Q2 2018

Aug 06, 2018

SELL
$102.37 - $117.25 $3.35 Million - $3.83 Million
-32,702 Reduced 4.0%
784,349 $88.1 Million
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $1.41 Million - $1.66 Million
14,391 Added 1.79%
817,051 $87.2 Million
Q4 2017

Feb 09, 2018

BUY
$100.43 - $118.09 $80.6 Million - $94.8 Million
802,660
802,660 $87.9 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.